Press Release
Leading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sectorCell and Gene Therapy Catapult focuses on strategic areas to further unlock the full potential of the UK advanced therapy industryCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerAutolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and InnovationCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterPress release: Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in EuropePress Release: UK ATMP Clinical Trials Database 2022: Number of Advanced Therapy Medicinal Product clinical trials in the UK continues to increase year-on-year